Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Cipla
Mallinckrodt
Dow
Queensland Health
AstraZeneca
UBS
Boehringer Ingelheim
Fuji

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019781

« Back to Dashboard

NDA 019781 describes PROMETRIUM, which is a drug marketed by Virtus Pharms and is included in one NDA. It is available from five suppliers. Additional details are available on the PROMETRIUM profile page.

The generic ingredient in PROMETRIUM is progesterone. There are fifty-five drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the progesterone profile page.
Summary for 019781
Tradename:PROMETRIUM
Applicant:Virtus Pharms
Ingredient:progesterone
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Pharmacology for NDA: 019781
Ingredient-typeProgesterone
Medical Subject Heading (MeSH) Categories for 019781
Suppliers and Packaging for NDA: 019781
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROMETRIUM progesterone CAPSULE;ORAL 019781 NDA AbbVie Inc. 0032-1708 N 0032-1708-01
PROMETRIUM progesterone CAPSULE;ORAL 019781 NDA AbbVie Inc. 0032-1711 N 0032-1711-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength100MG
Approval Date:May 14, 1998TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength200MG
Approval Date:Oct 15, 1999TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength300MG
Approval Date:Oct 15, 1999TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Medtronic
Cantor Fitzgerald
McKinsey
Chinese Patent Office
US Army
Argus Health
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.